FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1236888009: Product containing precisely diloxanide furoate 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5089553015 Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5089554014 Product containing precisely diloxanide furoate 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet Is a Product containing only diloxanide and metronidazole in oral dose form (medicinal product form) true Inferred relationship Some
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet Plays role Antiparasitic therapeutic role (role) false Inferred relationship Some
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Metronidazole (substance) true Inferred relationship Some 1
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Metronidazole (substance) true Inferred relationship Some 1
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Diloxanide furoate (substance) true Inferred relationship Some 2
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Diloxanide furoate (substance) true Inferred relationship Some 2
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start